Showing results (1-10 of 384) with videos related to

Sort By:
Pageof 39
The Journal of Urology|May 7, 2002
Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?Danil V Makarov, Harriete Sanderson, Alan W Partin, et al.
Annual Review of Medicine|October 25, 2008
Biomarkers for prostate cancerDanil V Makarov, Stacy Loeb, Robert H Getzenberg, et al.
Urology|March 29, 2008
Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?Ina Wu, Matthew E Nielsen, Misop Han, et al.
The Prostate|May 7, 2008
p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shapeSumit Isharwal, Michael C Miller, Cameron Marlow, et al.
Urology|February 19, 2008
Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?Matthew E Nielsen, Danil V Makarov, Elizabeth Humphreys, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 18, 2008
Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometryRobert W Veltri, M Craig Miller, Sumit Isharwal, et al.
The Journal of Urology|November 17, 2009
Validation of the partin nomogram for prostate cancer in a national sampleJames B Yu, Danil V Makarov, Richa Sharma, et al.
World Journal of Urology|December 15, 2010
Significance of preoperative PSA velocity in men with low serum PSA and normal DREDanil V Makarov, Stacy Loeb, Ahmed Magheli, et al.
The Journal of Urology|July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/mlDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
Pageof 39